Breast Reconstruction Options
On this page
Direct answer
Reconstruction choice balances three questions: how much skin the mastectomy removes, whether radiotherapy is planned or given, and what donor tissue the patient can spare. Implant-based reconstruction (tissue expander then implant, or direct-to-implant in a good envelope, increasingly prepectoral with acellular dermal matrix) suits mastectomies without radiotherapy; autologous reconstruction — the DIEP flap as modern gold standard, or pedicled latissimus dorsi with implant — tolerates radiotherapy better and gives the most natural, lasting result at the cost of microsurgical dependency. Immediate reconstruction at mastectomy (skin-sparing or nipple-sparing where oncologically safe) preserves the breast footprint and psychology; delayed reconstruction after radiotherapy accepts a harder bed but a safer plan. Oncological safety is not compromised in appropriately selected patients.
What you must remember
- Timing: immediate (with mastectomy — better cosmesis and body image, no extra anaesthetic for the base operation), delayed (weeks to years later, routine after radiotherapy), and delayed-immediate (expander as a placeholder while radiotherapy decisions mature).
- Implant pathway: two-stage tissue expander → implant (safe default) versus direct-to-implant in a good envelope; subpectoral placement risks animation deformity, prepectoral placement avoids it at the cost of needing good soft-tissue cover; acellular dermal matrix supports the lower pole.
- Autologous ladder: pedicled latissimus dorsi (reliable, often paired with an implant), pedicled or free TRAM, muscle-sparing free TRAM, and the DIEP perforator flap that preserves rectus function — the quoted gold standard; thigh-based options (TUG/PAP) when the abdomen is unavailable.
- Radiotherapy decides the debate: post-mastectomy radiotherapy markedly raises capsular contracture and implant loss — plan autologous tissue, or a delayed approach, when radiotherapy is likely; irradiated beds are also hostile to expander-based salvage.
- Flap surveillance: free flaps need hourly clinical checks (colour, turgor, capillary refill, temperature) for the first 24-48 hours in a monitored setting, with immediate return to theatre for thrombosis — total flap loss in experienced centres is of the order of 1-2%.
- Nipple and finishing: nipple-sparing mastectomy preserves the nipple-areola in selected low-risk patients; otherwise nipple reconstruction by local flap (CV/skate) plus tattooing, or three-dimensional tattoo alone; contralateral symmetrisation completes the aesthetic plan.
- Complications to list: capsular contracture, implant infection and exposure, seroma, fat necrosis, abdominal bulge or hernia after flap harvest, and lymphoedema after extensive nodal surgery.
- Oncoplastic caveat: for partial defects after wide local excision, volume displacement or replacement techniques (therapeutic mammoplasty, local perforator flaps such as LICAP/TDAP) are the breast-conserving arm of the same discipline.
Choosing in a real clinic
A 42-year-old with multifocal cancer and a BRCA2 mutation chooses risk-reducing bilateral mastectomy; no radiotherapy is planned. Nipple-sparing mastectomy with prepectoral direct-to-implant reconstruction, ADM support — a symmetrical single-operation result. Change one variable — post-mastectomy radiotherapy — and the answer flips: implants under radiotherapy court contracture and loss, so the plan becomes delayed autologous reconstruction, a DIEP flap by a microsurgical team. Change the patient instead — thin, smoker, previous abdominal surgery — and the latissimus dorsi plus implant, or a thigh-based flap, becomes the honest option. The clinical method: radiotherapy first, tissue availability second, preference and occupation third — with documented discussion of symmetry, nipple options and future implant replacement.
Perspective: exam and Indian practice
Theory questions are discriminating one-liners: which flap spares the rectus abdominis (DIEP), which reconstruction is contraindicated in planned post-mastectomy radiotherapy (implant-based, relative contraindication), which technique preserves the skin envelope (skin-sparing mastectomy, with nipple-sparing a step further). The viva angle is aesthetic-versus-safety: candidates must state that reconstruction does not compromise oncological clearance and that skin-sparing mastectomy does not increase local recurrence in appropriate tumours. Indian practice realities: implant-based reconstruction dominates metro private practice for cost and logistics, DIEP programmes live in tertiary centres, radiotherapy access dictates timing, and insurance coverage remains uneven — so the on-paper answer may need a resource-adapted version, and saying so explicitly is examiner-accepted.
Frequently asked questions
Which flap is considered the gold standard for autologous breast reconstruction?
The deep inferior epigastric perforator (DIEP) flap — lower abdominal skin and fat on perforating vessels, sparing the rectus muscle and its function.
Why is implant-based reconstruction problematic after radiotherapy?
Radiotherapy markedly increases capsular contracture, malposition and implant loss, so autologous tissue or delayed reconstruction is preferred when post-mastectomy radiotherapy is planned.
What is the difference between immediate and delayed reconstruction?
Immediate reconstruction is performed during the mastectomy, preserving the skin envelope and body image; delayed reconstruction follows healing (and usually radiotherapy), trading a better-irradiated-field plan for a second major operation.
What is a tissue expander and when is it used?
A temporarily implanted device inflated over weeks to stretch skin and muscle, creating space for the final implant — the two-stage standard when the skin envelope after mastectomy is tight.
How is the nipple-areola complex reconstructed?
By local flap techniques (CV or skate flap) with later tattooing, by three-dimensional medical tattoo alone, or by preservation during nipple-sparing mastectomy in carefully selected low-risk patients.